TECVAYLI J Code: J9380

Drug & Product Overview

HCPCS Descriptor Injection, teclistamab-cqyv, 0.5 mg

HCPCS Added Date July 1, 2023

Manufacturer Janssen

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection

About TECVAYLI

Tecvayli is a medication aligned to the HCPCS J Code: J9380 for billing, pricing, and reimbursement purposes in the United States. Classified under Misc., it is administered via the subcutaneous route and manufactured by Janssen.

According to CMS Drug Use Information: This medication is used to treat a certain type of cancer (multiple myeloma). Teclistamab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
57894-0449-01	Tecvayli	Janssen Biotech, Inc.	60	30 MG / 3 ML
57894-0450-01	Tecvayli	Janssen Biotech, Inc.	306	153 MG / 1.7 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

TECVAYLI Pricing & Reimbursement

J9380 Private Payer Reimbursement

$35.48 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

TECVAYLI Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 8.55%

Avg. Days to File 6.0days

Avg. Days to Pay 25.1days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9380 claims analytics on FocalPoint →

TECVAYLI CPT Administration Codes

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic

JW / JZ modifiers apply

CMS has identified Tecvayli (J9380) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

TECVAYLI Medically Unlikely Edits (MUE)

The most billing units of J9380 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.5 mg.

Practitioner Office & Hospital Outpatient

918 units / day

= 459 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

TECVAYLI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

relapsed or refractory multiple myeloma

Frequently Asked Questions

Is there an available Tecvayli billing and coding guide?

Billing and coding information for TECVAYLI can be found through Janssen Biotech, Inc.. Visit Here →

Are there any available Tecvayli patient assistance programs?

TECVAYLI patient assistance information can be found through Janssen Biotech, Inc.. Visit Here →

Where can I find Tecvayli prescribing information?

TECVAYLI prescribing information can be found at the link below: Visit Here →

Where can I find Tecvayli side effect information?

Information regarding TECVAYLI's side effects can be found at MedlinePlus Visit Here →

Does billing TECVAYLI require JZ/JW wastage modifiers?

CMS has identified TECVAYLI(J9380) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.